Skip to main content
Premium Trial:

Request an Annual Quote

Sophia Genetics: Peter Casasanto, Abhi Verma

Sophia Genetics has hired Peter Casasanto as chief biopharma officer and Abhimanyu (Abhi) Verma as chief technology officer. Casasanto, who has more than 15 years of experience in life sciences business development and sales, comes to Sophia after serving as VP of new commercialization initiatives for Canadian precision medicine laboratory services provider CellCarta. Verma previously had several leadership positions at Novartis, covering applied technology innovation, real-world evidence, drug development, enterprise technologies, IT strategy, data science, and artificial intelligence.

The Scan

Sensor to Spot SARS-CoV-2 Exposure

Yale researchers have developed a sensor that gauges SARS-CoV-2 exposure, according to the New Haven Register.

Watching BA.2

A subtype of the Omicron SARS-CoV-2 variant has been found in a number of countries, the Washington Post says.

Vermont Weighs Genetic Discrimination Bill

VT Digger reports Vermont legislators are considering a bill to bar insurer from denying customers coverage based on genetic information.

PNAS Papers on Convergent Pathogen Effectors, Lineage-Related RNA Mutations, Desiccation-Tolerant Grass

In PNAS this week: convergent evolution of pathogen effectors, algorithm to identify cell lineage features, and more.